Literature DB >> 23918983

Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model.

Kuldeep S Chattha1, Anastasia N Vlasova, Sukumar Kandasamy, Gireesh Rajashekara, Linda J Saif.   

Abstract

Rotaviruses (RVs) are a leading cause of childhood diarrhea. Current oral vaccines are not effective in impoverished countries where the vaccine is needed most. Therefore, alternative affordable strategies are urgently needed. Probiotics can alleviate diarrhea in children and enhance specific systemic and mucosal Ab responses, but the T cell responses are undefined. In this study, we elucidated the T cell and cytokine responses to attenuated human RV (AttHRV) and virulent human RV (HRV) in gnotobiotic pigs colonized with probiotics (Lactobacillus rhamnosus strain GG [LGG] and Bifidobacterium lactis Bb12 [Bb12]), mimicking gut commensals in breastfed infants. Neonatal gnotobiotic pigs are the only animal model susceptible to HRV diarrhea. Probiotic colonized and nonvaccinated (Probiotic) pigs had lower diarrhea and reduced virus shedding postchallenge compared with noncolonized and nonvaccinated pigs (Control). Higher protection in the Probiotic group coincided with higher ileal T regulatory cells (Tregs) before and after challenge, and higher serum TGF-β and lower serum and biliary proinflammatory cytokines postchallenge. Probiotic colonization in vaccinated pigs enhanced innate serum IFN-α, splenic and circulatory IFN-γ-producing T cells, and serum Th1 cytokines, but reduced serum Th2 cytokines compared with noncolonized vaccinated pigs (Vac). Thus, LGG+Bb12 induced systemic Th1 immunostimulatory effects on oral AttHRV vaccine that coincided with lower diarrhea severity and reduced virus shedding postchallenge in Vac+Pro compared with Vac pigs. Previously unreported intestinal CD8 Tregs were induced in vaccinated groups postchallenge. Thus, probiotics LGG+Bb12 exert divergent immunomodulating effects, with enhanced Th1 responses to oral AttHRV vaccine, whereas inducing Treg responses to virulent HRV.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23918983      PMCID: PMC4136549          DOI: 10.4049/jimmunol.1300678

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  68 in total

1.  HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes.

Authors:  Hong Jiang; Steve M Canfield; Mary P Gallagher; Hong H Jiang; Yihua Jiang; Zongyu Zheng; Leonard Chess
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

Review 2.  Probiotic modulation of dendritic cells and T cell responses in the intestine.

Authors:  M Meijerink; J M Wells
Journal:  Benef Microbes       Date:  2010-11       Impact factor: 4.205

Review 3.  Innate immunity: impact on the adaptive immune response.

Authors:  R Medzhitov; C A Janeway
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

Review 4.  2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; A Duncan Steele; Jazmin Duque; Umesh D Parashar
Journal:  Lancet Infect Dis       Date:  2011-10-24       Impact factor: 25.071

5.  Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs.

Authors:  L A Ward; B I Rosen; L Yuan; L J Saif
Journal:  J Gen Virol       Date:  1996-07       Impact factor: 3.891

6.  Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea.

Authors:  A Guarino; R B Canani; M I Spagnuolo; F Albano; L Di Benedetto
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-11       Impact factor: 2.839

7.  Antibiotics in early life alter the murine colonic microbiome and adiposity.

Authors:  Ilseung Cho; Shingo Yamanishi; Laura Cox; Barbara A Methé; Jiri Zavadil; Kelvin Li; Zhan Gao; Douglas Mahana; Kartik Raju; Isabel Teitler; Huilin Li; Alexander V Alekseyenko; Martin J Blaser
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

8.  Cytokines as mediators for or effectors against rotavirus disease in children.

Authors:  B Jiang; L Snipes-Magaldi; P Dennehy; H Keyserling; R C Holman; J Bresee; J Gentsch; R I Glass
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

9.  Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge.

Authors:  Monica M McNeal; Mitali Basu; Judy A Bean; John D Clements; Nils Y Lycke; Anna Ramne; Björn Löwenadler; Anthony H-C Choi; Richard L Ward
Journal:  Vaccine       Date:  2007-06-21       Impact factor: 3.641

Review 10.  Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model.

Authors:  Lijuan Yuan; Linda J Saif
Journal:  Vet Immunol Immunopathol       Date:  2002-09-10       Impact factor: 2.046

View more
  37 in total

1.  Protein Malnutrition Alters Tryptophan and Angiotensin-Converting Enzyme 2 Homeostasis and Adaptive Immune Responses in Human Rotavirus-Infected Gnotobiotic Pigs with Human Infant Fecal Microbiota Transplant.

Authors:  David D Fischer; Sukumar Kandasamy; Francine C Paim; Stephanie N Langel; Moyasar A Alhamo; Lulu Shao; Juliet Chepngeno; Ayako Miyazaki; Huang-Chi Huang; Anand Kumar; Gireesh Rajashekara; Linda J Saif; Anastasia N Vlasova
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

2.  In vivo gut transcriptome responses to Lactobacillus rhamnosus GG and Lactobacillus acidophilus in neonatal gnotobiotic piglets.

Authors:  Anand Kumar; Anastasia N Vlasova; Zhe Liu; Kuldeep S Chattha; Sukumar Kandasamy; Malak Esseili; Xiaoli Zhang; Gireesh Rajashekara; Linda J Saif
Journal:  Gut Microbes       Date:  2014-01-22

3.  Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8].

Authors:  Lulu Shao; David D Fischer; Sukumar Kandasamy; Abdul Rauf; Stephanie N Langel; David E Wentworth; Karla M Stucker; Rebecca A Halpin; Ham Ching Lam; Douglas Marthaler; Linda J Saif; Anastasia N Vlasova
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

Review 4.  Probiotics, antibiotics and the immune responses to vaccines.

Authors:  Ira Praharaj; Sushil M John; Rini Bandyopadhyay; Gagandeep Kang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

5.  Infectivity of GII.4 human norovirus does not differ between T-B-NK+ severe combined immunodeficiency (SCID) and non-SCID gnotobiotic pigs, implicating the role of NK cells in mediation of human norovirus infection.

Authors:  Thavamathi Annamalai; Zhongyan Lu; Kwonil Jung; Stephanie N Langel; Christopher K Tuggle; Jack C M Dekkers; Emily H Waide; Sukumar Kandasamy; Linda J Saif
Journal:  Virus Res       Date:  2019-05-02       Impact factor: 3.303

6.  Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model.

Authors:  Sukumar Kandasamy; Kuldeep S Chattha; Anastasia N Vlasova; Gireesh Rajashekara; Linda J Saif
Journal:  Gut Microbes       Date:  2014

7.  Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses.

Authors:  Anastasia N Vlasova; Lulu Shao; Sukumar Kandasamy; David D Fischer; Abdul Rauf; Stephanie N Langel; Kuldeep S Chattha; Anand Kumar; Huang-Chi Huang; Gireesh Rajashekara; Linda J Saif
Journal:  Eur J Immunol       Date:  2016-08-11       Impact factor: 5.532

8.  Differential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus Strain GG on Human Rotavirus Binding, Infection, and B Cell Immunity.

Authors:  Sukumar Kandasamy; Anastasia N Vlasova; David Fischer; Anand Kumar; Kuldeep S Chattha; Abdul Rauf; Lulu Shao; Stephanie N Langel; Gireesh Rajashekara; Linda J Saif
Journal:  J Immunol       Date:  2016-01-22       Impact factor: 5.422

Review 9.  Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species.

Authors:  Anastasia N Vlasova; Sukumar Kandasamy; Kuldeep S Chattha; Gireesh Rajashekara; Linda J Saif
Journal:  Vet Immunol Immunopathol       Date:  2016-01-14       Impact factor: 2.046

10.  A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis.

Authors:  M Rigo-Adrover; S Saldaña-Ruíz; K van Limpt; K Knipping; J Garssen; J Knol; A Franch; M Castell; F J Pérez-Cano
Journal:  Eur J Nutr       Date:  2016-04-25       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.